SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹4.98 Cr | ₹4.42 Cr | ₹4.58 Cr | ₹7.16 Cr | ₹5.85 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹4.98 Cr |
Mar2023 | ₹4.42 Cr |
Mar2022 | ₹4.58 Cr |
Mar2017 | ₹7.16 Cr |
Mar2016 | ₹5.85 Cr |
How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.98 Cr | 12.55 | |
Mar2023 | ₹4.42 Cr | -3.34 | |
Mar2022 | ₹4.58 Cr | -36.07 | |
Mar2017 | ₹7.16 Cr | 22.41 | |
Mar2016 | ₹5.85 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,003.1 Cr | -3.3% | 21.7% | 73.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -3.3% |
21.7% |
73.7% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses